Literature DB >> 17998578

Cytogenetic analysis of Down syndrome in Gujarat.

Frenny Sheth1, Subhada Rao, Manisha Desai, Jigna Vin, Jayesh Sheth.   

Abstract

During 1995 to 2006, 382 cases clinically suspected for Down syndrome were investigated for cytogenetic study. Free trisomy 21 constituted 84.8% of cases, translocation 8.9%, mosaic 3.9% and in 2.4% cases regular T21 was associated with structural or numerical changes. Translocation was parentally inherited in 26.5% cases and maternal transmission was twice as common as paternal. Males were more pronounced to be affected than females in all the groups. 91.6% of DS babies were born to younger mothers (20-35 yr) compared to 8.4% in elderly mothers (>35 yr).

Mesh:

Year:  2007        PMID: 17998578

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  5 in total

Review 1.  Down Syndrome Screening in India: Are We There Yet?

Authors:  K Manikandan; Suresh Seshadri
Journal:  J Obstet Gynaecol India       Date:  2017-08-17

2.  Cardiac spectrum, cytogenetic analysis and thyroid profile of 418 children with Down syndrome from South India: a cross-sectional study.

Authors:  Dhanya Lakshmi Narayanan; Dhanya Yesodharan; Mahesh Kappanayil; Shwetha Kuthiroly; M V Thampi; Zareena Hamza; Alka Anilkumar; K Mohandas Nair; K R Sundaram; R Krishna Kumar; Sheela Nampoothiri
Journal:  Indian J Pediatr       Date:  2013-08-10       Impact factor: 1.967

3.  Cytogenetic and comorbidity profile of Down syndrome in Mansoura University Children's Hospital, Egypt.

Authors:  Abdel-Hady El-Gilany; Sohier Yahia; Mohamed Shoker; Faeza El-Dahtory
Journal:  Indian J Hum Genet       Date:  2011-09

Review 4.  Prenatal screening for genetic disorders: Suggested guidelines for the Indian Scenario.

Authors:  Shubha R Phadke; Ratna D Puri; Prajnya Ranganath
Journal:  Indian J Med Res       Date:  2017-12       Impact factor: 2.375

5.  Performance of second-trimester maternal biochemistry screening (quadruple test vs. triple test) for trisomy 21: An Indian experience.

Authors:  Aanchal Sablok; Akshatha Sharma; Chanchal Singh Ahmed; Anita Kaul
Journal:  Indian J Med Res       Date:  2021-05       Impact factor: 5.274

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.